Dr. Luis E. Raez
@LuisRaezMD
Followers
1K
Following
2K
Media
367
Statuses
2K
Chief Sci Off & Med Dir Memorial Can Inst/Memorial Health Syst Past Pres. FLASCO, old account @luiseraez1 was dc, personal site
Miami, FL
Joined April 2023
We are publishing EGFR resistant tumor data here after profiling more than 45,000 tumors, the documentation of the prevalence of resistance mutations (718,721,797 etc.) is very important however we need to increase awareness to repeat molecular profiling after TKI failure to have
4
27
101
Congrats to our fellows Velez and Dweik from @MCIStrong @mhshospital for this good ALK review in @NCODAorg journal "Oncolytics today" @DocOncMD @drhunis @castrellon_md @mci
https://t.co/sOEfUmwJXo
@ALKPositiveinc @ALKpositiveINT #lungcancer #lcsm
0
0
6
🚨 Registration is open for the 2025 MaTOS Lung! 🫁 Join us for a 3-day deep dive into the future of lung cancer care. 🔗 https://t.co/UbwbV2IP7q 📅 Don’t miss out! Sponsorship opportunities are available @EddieSantosMD @LuisRaezMD @KarenReckampMD #MaTOSLung2025
0
2
15
📢 Registration is now OPEN for the 2026 Updates in Cancer Therapies (UCT) Conference! Join leading oncology experts for two days of cutting-edge insights, panel discussions, and interactive Q&A. Let’s move forward—together Register Now! - https://t.co/o5oe8o2S8V
#UCT2026
0
1
2
0
0
2
Our @FLASCO_ORG "Breaking Barriers" Conference is coming this November again! we are addressing topics to improve cancer care in Veterans, rural communities, minorities and other disadvantage populations with @Latinamd @BrainTumorDoc @EugeneManley
@MikeCusnir @BlasePolite from
0
2
8
If you have not had a chance yet to review here is the link for the 2025 @ASCO and @NCODAorg standards for dispensation of oral oncolytics in the @JCOOP_ASCO we have more than 1,800 downloads in the first 3 months! with @KashyappatelMd from @oncologyCOA @Doshi1G from
0
1
5
it will be very interesting if tarlatamab maintenance is also approved soon for SCLC how we are going to decide what is the best maintenance for our patients, anyway we are happy to have better options for them @SclcSMASHERS @triparnasen @drshieldsmd #lungcancer #LCSM
0
4
8
FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs for extensive-stage small cell lung cancer Learn more 👉 https://t.co/lssNE6vBDR
#LARVOL #Oncology #CancerResearch #CancerData #Oncologylnsights #FDAApproval #SCLC #LungCancer |
0
7
17
More and better options for our patients with small cell lung cancer with improve OS of 3 months! @SclcSMASHERS @genentech #lungcancer #lcsm @JazzPharma
The @US_FDA has approved lurbinectedin + atezolizumab OR atezolizumab + hyaluronidase-tqjs as maintenance for adults with ES-SCLC without progression on first-line atezolizumab ± hyaluronidase-tqjs, carboplatin, etoposide #FDAApproval #SCLC
https://t.co/kqtrz04fmO
0
0
0
Our 2025 Spanish Targeted Therapies @cancerGRACE Forum live webinar videos are in! if you want to review them discussing the most important topics in targeted therapy (EGFR, ALK, ROS1,etc) @DocOncMD @EGFRResisters @EGFRSummit @EgfrUk @egfr @EGFRmNSCLC @DFEGFRcenter
1
3
10
Outstanding #lungcancer module at the #SmeO2025 national meeting! Most interesting debates were about the need of adjuvant IO therapy? after neoadjuvant IO with pCR and/or cleared ctDNA with @ogarrieta @delvysra @MCIStrong @mhshospital @JorgeAlatorreA1
0
1
6
Outstanding #lungcancer module at the #SmeO2025 national meeting! Most interesting debates were about the need of adjuvant IO therapy? after neoadjuvant IO with pCR and/or cleared ctDNA with @ogarrieta @delvysra @MCIStrong @mhshospital @JorgeAlatorreA1
0
1
6
🚨 Nos vemos mañana viernes 26 en el módulo de Oncología Torácica del #CongresoSMeO2025 🇲🇽 @SMEOMX. Iniciamos a las 9:00 am en el salón 5. 🤓✌🏻 @DrLuisCM @ogarrieta @delvysra @LuisRaezMD @NeumopatoGdl @drcoronacruz @maritza_rramos
#SMeO #OncologiaMX
0
0
5
peroperative immunotherapy
@diegoadiazg @SMEOMX @DrLuisCM @ogarrieta @delvysra @LuisRaezMD @NeumopatoGdl @drcoronacruz @maritza_rramos Sounds like an exciting session! What key topics in thoracic oncology are you most looking forward to highlighting at #SMeO2025?
0
0
2
Thanks to DRIVEN for this interview, we had a lot of new developments in #lungcancer this year! #lungcancer #lcsm @MCIStrong @mhshospital @FLASCO_ORG @OLACANCER1 Leading the Fight Against Lung Cancer: Dr. Luis Raez’s Global Impact https://t.co/2ItWVQI4J5 via @YouTube
2
0
8
Congrats to @AndresFCardonaZ @ogarrieta and the @CLICaP_ team for his publication about #RET fusions in #lungcancer in LATAM and thanks for this collaboration @MCIStrong @mhshospital @FLASCO_ORG @OLACANCER1 @ChristianRolfo @RETpositive @DrClaudiomartin
https://t.co/f2keiKnIoX
1
5
27